CME Group Inc. $CME Shares Acquired by Meyer Handelman Co.

Meyer Handelman Co. increased its position in shares of CME Group Inc. (NASDAQ:CME) by 16.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 71,549 shares of the financial services provider’s stock after purchasing an additional 9,977 shares during the quarter. Meyer Handelman Co.’s holdings in CME Group were worth $19,332,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Jessup Wealth Management Inc lifted its position in shares of CME Group by 0.5% in the 2nd quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock worth $2,197,000 after buying an additional 36 shares during the last quarter. First Horizon Advisors Inc. grew its position in shares of CME Group by 0.7% during the 2nd quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock valued at $1,453,000 after buying an additional 36 shares during the last quarter. Great Lakes Advisors LLC raised its stake in CME Group by 2.3% during the first quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock worth $441,000 after acquiring an additional 37 shares during the period. MBM Wealth Consultants LLC lifted its holdings in CME Group by 2.7% in the second quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock worth $392,000 after acquiring an additional 37 shares during the last quarter. Finally, Beaumont Financial Advisors LLC boosted its stake in CME Group by 2.0% in the second quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider’s stock valued at $538,000 after acquiring an additional 38 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

CME has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft increased their price target on CME Group from $310.00 to $318.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. Raymond James Financial dropped their target price on CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a research report on Monday, October 13th. Morgan Stanley boosted their price target on shares of CME Group from $314.00 to $320.00 and gave the company an “overweight” rating in a report on Monday. TD Cowen upped their price target on shares of CME Group from $288.00 to $290.00 and gave the stock a “hold” rating in a research report on Thursday, October 23rd. Finally, The Goldman Sachs Group cut their price objective on shares of CME Group from $264.00 to $263.00 and set a “sell” rating on the stock in a research report on Thursday, December 4th. Eight equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $290.82.

Insider Activity at CME Group

In other CME Group news, CEO Terrence A. Duffy sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the sale, the chief executive officer directly owned 65,804 shares in the company, valued at $17,737,468.20. This represents a 27.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of CME Group stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the transaction, the director owned 1,091 shares in the company, valued at approximately $287,511.23. This trade represents a 47.82% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.30% of the company’s stock.

CME Group Trading Up 0.1%

NASDAQ:CME opened at $276.73 on Friday. The stock has a market cap of $99.79 billion, a price-to-earnings ratio of 26.81, a PEG ratio of 3.72 and a beta of 0.28. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 1 year low of $224.62 and a 1 year high of $290.79. The business has a fifty day moving average of $273.14 and a 200-day moving average of $271.85.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.63 by $0.05. The business had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The company’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.68 earnings per share. Equities analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s dividend payout ratio is currently 48.45%.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.